<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="4135">
  <stage>Registered</stage>
  <submitdate>19/09/2013</submitdate>
  <approvaldate>19/09/2013</approvaldate>
  <nctid>NCT01970189</nctid>
  <trial_identification>
    <studytitle>The International ITP Registry</studytitle>
    <scientifictitle>A Multi-centre, Prospective Disease Registry for Adults Diagnosed With Primary Immune Thrombocytopenia (ITP) in International Countries</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>CTBR-017 (TRA114972)</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Thrombocytopenia</healthcondition>
    <conditioncode>
      <conditioncode1>Blood </conditioncode1>
      <conditioncode2>Haematological diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Blood </conditioncode1>
      <conditioncode2>Other blood disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Autoimmune diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Primary Immune Thrombocytopaenia - Recently-diagnosed (i.e. &lt; 6 months) primary ITP adult patients (= 18 years) characterized by platelet counts less than 100x109/L as defined by the International Working Group.

</interventions>
    <comparator />
    <control />
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Disease progression of ITP - This will include response assessment to each treatment modality, incidence and characteristics of bleeding events, bone marrow results (if available), development of refractory ITP and effects of any medical intervention (whether beneficial or detrimental) in the overall severity of the disease, according to definitions described by the ITP International Working Group.</outcome>
      <timepoint>up to 24 months</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. Recently-diagnosed (i.e. &lt; 6 months) primary ITP adults patients (= 18 years)
             characterized by platelet counts less than 100x109/L as defined by the International
             Working Group1.

          2. Able to provide written consent for data to be included in the registry</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria />
  </eligibility>
  <trial_design>
    <studytype>Observational [Patient Registry]</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/01/2011</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>500</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/12/2020</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>ACT,NSW,SA,VIC</recruitmentstate>
    <hospital>Canberra Hospital - Canberra</hospital>
    <hospital>St George Hospital - Sydney</hospital>
    <hospital>Calvary Mater Newcastle - Sydney</hospital>
    <hospital>Concord Hospital - Sydney</hospital>
    <hospital>Liverpool Hospital - Sydney</hospital>
    <hospital>Prince of Wales Hospital - Sydney</hospital>
    <hospital>Flinders Medical Centre - Adelaide</hospital>
    <hospital>Royal Adelaide Hospital - Adelaide</hospital>
    <hospital>St Vincent's Hospital - Melbourne</hospital>
    <hospital>The Alfred - Melbourne</hospital>
    <postcode> - Canberra</postcode>
    <postcode>2217 - Sydney</postcode>
    <postcode> - Sydney</postcode>
    <postcode> - Adelaide</postcode>
    <postcode> - Melbourne</postcode>
    <countryoutsideaustralia>
      <country>Colombia</country>
      <state>Busaramanga</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Colombia</country>
      <state>Colombia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Korea, Republic of</country>
      <state>Seoul</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Kuwait</country>
      <state>Kuwait City</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Malaysia</country>
      <state>Kuala Lumpur</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Malaysia</country>
      <state>Penang</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Singapore</country>
      <state>Singapore</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Taiwan</country>
      <state>Taipei</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Taiwan</country>
      <state>TAiwan</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Taiwan</country>
      <state>Taiwan</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Taiwan</country>
      <state>Taiwean</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Thailand</country>
      <state>Bangkok</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Thailand</country>
      <state>Chiang Mai</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Thailand</country>
      <state>Thailand</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Ankara</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>PAmukkale</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Turkey</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Uruguay</country>
      <state>Uruguay</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>South Eastern Sydney Local Health District</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Commercial sector/Industry</othercollaboratortype>
      <othercollaboratorname>GlaxoSmithKline</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Primary immune thrombocytopenia (ITP) is an uncommon disease characterised by a low platelet
      count, which may cause the patient to have a higher risk or increased duration of bleeding.
      Individual hospitals only encounter a small number of ITP patients each year which makes it
      difficult to study this disease. By creating this disease registry, we will be able to build
      a more complete picture of ITP, including treatment practices, through collecting information
      about the condition from patients across several hospitals in several countries. Research of
      this kind will help future patients by providing doctors with information about ITP, and
      about how patients have been treated.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01970189</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Beng H Chong</name>
      <address>SESLHD</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Beng H Chong, Professor</name>
      <address />
      <phone>+612 91133426</phone>
      <fax />
      <email>benghock.chong@health.nsw.gov.au</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>